Access to Information Requests Completed - April 2011

This content was archived on June 24, 2013.

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.

Completed Requests

For the month of April 2011

Request #	Request text summary	Status of Completed Request	Number of Pages Disclosed
A-2009-00244	All information from the Director General Steering Committee on Jordan's Principle. (Jan 1, 2007 to May 29, 2009).	Disclosed in part	24
A-2009-00773	Information regarding the product APO-Pantoprazole, DINs 02292912 and 0229290 by Apotex Inc.	Disclosed in part	877
A-2009-01191	All documents in relation to the Canadian Agency for Drugs and Technologies in Health (CADTH) Therapeutic Review Pilot Project report. (Jan 19, 2008 to Jan 19, 2010).	All disclosed	193
A-2009-01231	Blank checklist used by GMP inspectors during on-site Drug GMP Compliance inspections of domestic facilities.	Disclosed in part	18
A-2009-01394	All contracts awarded anytime during the month of January 2009 pertaining to the following procurement vehicles: Temporary Help Services Supply Arrangement, Professional Services on-line and Task-based Informatics Professional Services (TBIPS).	Disclosed in part	708
A-2010-00059	All records relating to the medical device recall for: Recall number 51631 (Zimmer GMBH - Durom Acetabular Cup) and Zimmer Inc. Correction and Removal number 9613350-07/15/2008-001-C (Zimmer Inc. - Durom Acetabular Component). (Jun 1, 2008 to Apr 13, 2010).	Disclosed in part	258
A-2010-00104	Integrated Environmental Compliance and Facility Condition Audits at Health Canada - funded First Nations Health Facilities in the Quebec, Ontario and Atlantic Regions. Referenced in a Request for Proposals issued Aug 7, 2009 (number: 1000103543).	Disclosed in part	3,175
A-2010-00111	All records pertaining to any trade or consumer complaint filed against the following company: Medical Futures Inc.	Disclosed in part	91
A-2010-00156	Information regarding the product Colgate Sensitive Pro-Relief, NPN 80017891 by Colgate Palmolive Canada Inc.	Disclosed in part	373
A-2010-00226	All documentation regarding serious and unexpected adverse drug reactions at Biovail from 2002 to present (Jun 1, 2010).	Disclosed in part	267
A-2010-00517	Consideration of the complaint lodged on April 13, 2009 addressed to the Minister of Health, the drafting of the contents of the Minister's letter of September 16, 2009 and the recommendation to the Minister to send that letter.	All disclosed	32
A-2010-00535	All records dated January 2007 to present (July 28, 1010) related to an infant formula company with the following brand name: Kirkland.	Disclosed in part	109
A-2010-00584	Reports of health and safety incidents involving consumer products and/or cosmetics submitted through the form 'Consumer Product Incident Report Form CPS-SPC-0001.01. (Jan 1, 2010 to Aug 15, 2010).	Disclosed in part	858
A-2010-00604	Information regarding the product efavirenz (brand name 'SUSTIVA') by DuPont Pharma Inc., and Bristol Myers Squibb Canada.	Disclosed in part	648
A-2010-00615	All docs from Apr 2008 to present (Aug 23, 2010) regarding Novo-methylphenidate ER-C between Health Canada and other parties unrelated to Novopharm Ltd.	Disclosed in part	4
A-2010-00725	AERs for the product Lipitor (atorvastatin calcium). Report numbers: 000126839, 000131237, 000137678, 000137814, 000139013, 000154384, 000155919, 000157653, 000162857, 000164648 and 000179304.	Disclosed in part	35
A-2010-00755	Copy of all documents that enable me to see how much money is owed to Health Canada with respect to people authorized by law to use marijuana/pot legally since the government has authorized people with medical conditions to use marijuana.	Disclosed in part	31
A-2010-00804	A list of compounds, substances, chemicals, plants or animals currently under review relating to the unscheduled drug Mephedrone and similar substances.	Disclosed in part	17
A-2010-00913	All inspection reports, correspondence and recall documents produced by Health Canada regarding Pharmalogic Pet Services of Montreal Company for 2009 and 2010.	Disclosed in part	60
A-2010-00957	Information regarding the product NIASPAN FCT by Sepracor Pharmaceuticals Inc.	Disclosed in part	311
A-2010-00995	All correspondence in connection to the communication sent by Refreshments Canada's President Mr. Justin Sherwood to Health Canada's Deputy Minister Glenda Yeates. (Dec 3, 2010 to Dec 20, 2010).	Disclosed in part	15
A-2010-01037	Information regarding the product OSTO-D2, DIN 02301911 by Trinton Pharma Inc.	All disclosed	9
A-2010-01055	The conclusion report or any information between Health Canada and LePage, directly involving the product PL400.	Disclosed in part	60
A-2010-01069	Information related to all consultations, generally speaking, food safety, nutrition and quality were issues for which consultations were based. Specifically: Public involvement performance reports. (Jan 1, 2004 to Dec 21, 2010).	All disclosed	26
A-2010-01072	Information related to all consultations, generally speaking, food safety, nutrition and quality were issues for which consultations were based. Specifically: Full reports of all public opinion research in regards to food (consumption, safety, perception, nutrition, handling), as well as chemical, antimicrobial and environmental contaminants in food . (Jan 1, 2004 to Dec 21, 2010).	All disclosed	3,310
A-2010-01117	AER. Report number: 000302778.	Disclosed in part	8
A-2010-01154	Documents related to the submission made by Monsanto Canada Inc. for food approval for the Colorado Potato Beetle and Potato Leaf Roll Virus resistant potato (Lines RBMT21-129, RBMT21-350 and RBMT22-082).	Disclosed in part	105
A-2010-01179	Information regarding the product Crest Pro-Health; Crest Clean; Crest Pro-Health Night; Crest Pro-Health Sensitive Shield, NPN 80001224.	Disclosed in part	77
A-2010-01219	Information on the administering of the Access to Information Act in your department.	All disclosed	115
A-2010-01246	Approved indications and copy of approved 'Instructions for Use' manual for Medtronic's Integrity Stent (Licence number 84904).	Disclosed in part	14
A-2010-01258	Product Monographs of the drug Tylenol Arthritis Pain, DIN 02238885. Approval date: 1999-11-10.	No records exist	0
A-2010-01259	Product Monographs of the drug Tylenol Muscle Aches & Body Pain, DIN 02246060. Approval date: 2002-11-01.	No records exist	0
A-2010-01260	All appointments Term and Casual employees in the National Capital Region for the month of January 2011.	All disclosed	1
A-2010-01266	All local purchase orders for the procurement of Temporary Help Services in the National Capital Region for the month of January 2011.	All disclosed	6
A-2010-01271	Records of requests for legal opinions, since January 2004, and the responses from Legal Services to those requests by staff NHPD in relation to Parts 2 and 3 of the Natural Health Products Regulations (sections 26 through 62). (Jan 1 2004 to Feb 9, 2011).	Disclosed in part	47
A-2010-01315	Original complaint regarding the registration status of the product NRG.	Disclosed in part	9
A-2010-01344	Copies of any memorandum, email from Health Canada representatives with respect to any AERs in connection with CEFPROZIL. From January 2009 to February 23, 2011.	No records exist	0
A-2010-01347	Copies of any memorandum, email from Health Canada representatives with respect to any AERs in connection with CYCLOBENZAPRINE.	Disclosed in part	111
A-2010-01351	Copies of any memorandum, email from Health Canada representatives with respect to any AERs in connection with TOPIRAMATE. From January 2009 to February 23, 2011.	Disclosed in part	140
A-2010-01352	Copies of any memorandum, email from Health Canada representatives with respect to any AERs in connection with MIRTAZAPINE. From January 2009 to February 23, 2011.	Disclosed in part	3
A-2010-01385	Contract documents for contract H355182081. Contract Period: 2009-06-09 to 2012-03-31	No records exist	0
A-2010-01388	AERs for the product Synagis. Report numbers: 000342440 and 000344103.	Disclosed in part	2
A-2010-01389	AER for the product Synthroid. Report number: 000345714.	Disclosed in part	1
A-2010-01400	Any Health Canada document confirming that methadone is metabolized by cytochrome P450 enzymes and p-glycoprotein.	Disclosed in part	10
A-2010-01404	Full underlying reports and any other information relating to the repeated-dose toxicology studies performed in rats and in dogs using Andriol (testosterone undecanoate).	All exempted	0
A-2010-01410	All minutes of the Playpens and Cribs and Cradles Committees, from July 1, 2010 to February 25, 2011.	All disclosed	1
A-2010-01430	AER for the product Epival. Report number: 000347270.	Disclosed in part	1
A-2010-01431	AER for the product Synagis. Report number: 000350353.	Disclosed in part	2
A-2010-01436	Total costs related to the provision of primary health care services (nursing) for the community of Long First Nation (Winneway, Quebec) for the fiscal years of 2005-2006 to 2009-2010.	All disclosed	7
A-2010-01442	All records related to a list of communities in Northern Canada deemed to dangerous for Health Canada staff to travel because of high rates of infectious disease.	No records exist	0
A-2010-01443	Any correspondence from Health Canada Staff refusing to visit communities in Northern Canada over their fear of infectious diseases such as Tuberculosis and Hepatitis.	No records exist	0
A-2010-01454	All records regarding the medical device Cholesterol 123 test system (Device License number 27225) recall info.	No records exist	0
A-2010-01455	All records regarding the medical device D.TECT Coronary Heart Disease Predictor (Device License number 61466) recall info.	No records exist	0
A-2010-01456	All records regarding the medical device PreVu LT (Device License number 72408) recall info.	No records exist	0
A-2010-01489	AERs for the product Cipralex (ascitalopram). Report numbers: 000347288 and 000348464.	Disclosed in part	2
A-2010-01491	AER for the product Fluanxol (flupenthixol). Report number: 000349846.	Disclosed in part	3
A-2010-01510	Information regarding the product Crest ProHealth, NPN 80001224.	Disclosed in part	315
A-2010-01527	All documents relating to RJ-Wholesaler/ Supplier/ Distributor-Modern & Traditional Goods, with respect to the manufacture and/ or sale of tobacco products. (Jan 1, 2000 to Mar 23, 2010).	No records exist	0
A-2010-01528	AERs for the product Aleve. Report numbers: 000352833, 000353846, 000352554 and 000358294.	Disclosed in part	5
A-2010-01530	AER for the product One A Day. Report number: 000357128.	Disclosed in part	1
A-2010-01531	AERs for the product Canesten. Report numbers: 000354168 and 000356069.	Disclosed in part	2
A-2010-01532	AERs for the product CanesOral. Report numbers: 000356055, 000353688 and 000356825.	Disclosed in part	3
A-2010-01542	AERs for the product Avelox. Report numbers: 000357023, 000357847, 000358538 and 000358695.	Disclosed in part	5
A-2010-01543	AERs for the product Levitra. Report numbers: 000358068 and 000358507.	Disclosed in part	4
A-2010-01544	AER for the product Magnevist. Report number: 000358472.	Disclosed in part	1
A-2010-01545	AERs for the product Mirena. Report numbers: 000356657 and 000358274.	Disclosed in part	4
A-2010-01546	AERs for the product Nexavar. Report numbers: 000357712 and 000357855.	Disclosed in part	5
A-2010-01547	AERs for the product Xarelto. Report numbers: 000356525 and 000356904.	Disclosed in part	4
A-2010-01548	AERs for the product Yaz. Report numbers: 000357487 and 000358200.	Disclosed in part	2
A-2010-01549	Information regarding the product Cyklopron, DIN 02064413 by Pfizer Canada Inc.	No records exist	0
A-2010-01556	Information regarding the product Dalacin C Phosphate, DIN 00260436 by Pfizer Canada Inc.	No records exist	0
A-2010-01560	Information regarding the product Clindamycin Injection USP, DIN 02139286 by Pharmaceutical Partners of Canada Inc.	No records exist	0
A-2010-01562	Information regarding the product Vinblastine Sulphate Injection, DIN 02183056 by Hospira Health Corporation.	No records exist	0
A-2010-01569	Procedures, guidelines and policies established within Health Canada for processing ATI requests.	All disclosed	37
A-2010-01600	Information regarding the product VICTOZA, DINs 02351056 and 02351064 by NOVONORDISK CANADA INC.	No records exist	0
A-2010-01603	Information regarding the product BYETTA, DINs 02361809 and 02361817 by ELI LILLY CANADA INC.	All exempted	0
A-2011-00002	AER for the product Lupron. Report number: 000351461.	Disclosed in part	2
A-2011-00005	Information regarding the product D-FORTE, DIN 02237450 by Euro-Pharm international Canada Inc.	No records exist	0
A-2011-00015	Number of SAP releases for Dacogen (Decitabine) for the month of March 2011.	All disclosed	1
A-2011-00020	Number of SAP releases for Treanda (Bendamustine) for the month of March 2011.	All disclosed	1
A-2011-00023	Number of SAP releases for Halaven (Eribulin Mesylate) for the month of March 2011.	All disclosed	1
A-2011-00081	Previously released request A-2009-00866: Audit of the Electronic Health Information System (Infoway).	All disclosed	48